Seeking AlphaCodex · 实盘不做把握 9/10
北京时间·🕒 发布 19:34:20时区推断·⟳ 抓取 19:40:14·⚡ 决策 07-28 19:42:32 +2m18s·90.9 天前
Kiniksa二季度ARCALYST收入超预期并上调全年收入指引的Seeking Alpha转述
本条Seeking Alpha快讯披露Kiniksa二季度EPS小幅超预期、收入同比增长55.4%，并将2026年ARCALYST收入指引由9.30亿-9.45亿美元上调至9.80亿-9.95亿美元。
📄 原文Seeking Alpha↗ 原文
- Kiniksa Pharmaceuticals International, plc press release (KNSA): Q2 GAAP EPS of $0.30 beats by $0.01. - Revenue of $2…
不做 Kiniksa Pharmaceuticals（KNSA.US）
命中近72小时已处理且已推卡的同一具体催化：Kiniksa二季度ARCALYST销售超预期并上调2026年收入指引；本条Seeking Alpha仅为媒体转述，不重复出交易。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-28 · 扩散 medium · price-in 风险 high ↗
关键理由
- 本条Seeking Alpha快讯披露Kiniksa二季度EPS小幅超预期、收入同比增长55.4%，并将2026年ARCALYST收入指引由9.30亿-9.45亿美元上调至9.80亿-9.95亿美元。
- 但近72小时已处理并推卡同一具体催化：Kiniksa二季度ARCALYST销售超预期并上调2026年收入指引，本条只是同一财报事实的媒体转述。
主要风险
- 重复推送会对同一Kiniksa财报催化重复出卡，按去重纪律不再交易。
工具调用 · 历史记录,结果未知(1 种)
- search_processed_events · 结果未知
原文全文
展开原文 · 660 字
- Kiniksa Pharmaceuticals International, plc press release (KNSA): Q2 GAAP EPS of $0.30 beats by $0.01.
- Revenue of $243.6M (+55.4% Y/Y) beats by $17.14M.
- ARCALYST net product revenue was $243.6 million for the second quarter of 2026.
- As of the end of the second quarter of 2026, approximately 21% of the 14,000 multiple-recurrence patients were actively on ARCALYST treatment.
-
Financial Guidance
- Kiniksa expects 2026 ARCALYST net product revenue of between $980 million and $995 million, compared to prior guidance of between $930 million and $945 million.
- Kiniksa expects its current operating plan to remain cash flow positive on an annual basis.
- Revenue of $243.6M (+55.4% Y/Y) beats by $17.14M.
- ARCALYST net product revenue was $243.6 million for the second quarter of 2026.
- As of the end of the second quarter of 2026, approximately 21% of the 14,000 multiple-recurrence patients were actively on ARCALYST treatment.
-
Financial Guidance
- Kiniksa expects 2026 ARCALYST net product revenue of between $980 million and $995 million, compared to prior guidance of between $930 million and $945 million.
- Kiniksa expects its current operating plan to remain cash flow positive on an annual basis.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。